Armin Schwarzbach, MD, PhD - Lyme Borreliosis (2017 Conference) (LDN, low dose naltrexone)

Lyme borreliosis symptoms and coinfections, modern lab tests, new therapy options in chronic Lyme disease

Tom O'Bryan, DC - Fire in the Hole: Intestinal Permeability (2017 Conference) (LDN, low dose naltrexone)

Paul Battle PA-C - A Novel Approach to Type 1 Diabetes Mellitus (2017 Conference) (LDN, low dose naltrexone)

Mark Cooper, PhD - LDN, Neuroinflammation, and Movement Disorders (2018 Conference) (LDN, low dose naltrexone)

John Bardsley - Using unlicensed medicines as a part of patient care (2018 Conference) (LDN, low dose naltrexone)

John Bardsley is a pharmacist who has spent 15 years in the supply chain managing small to medium sized businesses in terms of GMP manufacture and GDP distribution throughout the UK. 

Jill Cottel, MD - Treatment of Chronic Pain in a Free Clinic Setting (2019 Conference) (LDN, low dose naltrexone)

Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease (2019 Conference) (LDN, low dose naltrexone)

Angus Dalgleish, MD - The role of LDN in cancer management (2019 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health II (2019 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health I (2019 Conference) (LDN, low dose naltrexone)